A SINGLE-ARM, OPEN-LABEL, LONG-TERM EFFICACY AND SAFETY STUDY OF SUBCUTANEOUS ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA

被引：0
|
作者：
Grainger, J. [1 ]
Bussel, J. [2 ]
Cooper, N. [3 ]
Tarantino, M. [4 ]
Blanchette, V. [5 ]
Despotovic, J. [6 ]
Maschan, A. [7 ]
Carpenter, N. [8 ]
Eisen, M. [9 ]
Mehta, B. [9 ]
机构：
[1] Univ Manchester, Manchester, Lancs, England
[2] Weill Cornell Med, New York, NY USA
[3] Imperial Coll, Hammersmith Hosp, London, England
[4] Bleeding & Clotting Disorders Inst, Peoria, IL USA
[5] Hosp Sick Children, Toronto, ON, Canada
[6] Texas Childrens Hematol Ctr, Houston, TX USA
[7] Fed Res Ctr Pediat Hematol Oncol & Immunol, Moscow, Russia
[8] Amgen Ltd, Uxbridge, Middx, England
[9] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P367
引用
收藏
页码：124 / 125
页数：2
相关论文
共 50 条
  • [41] Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study
    Durgam, Suresh
    Greenberg, William M.
    Li, Dayong
    Lu, Kaifeng
    Laszlovszky, Istvan
    Nemeth, Gyorgy
    Migliore, Raffaele
    Volk, Stephen
    PSYCHOPHARMACOLOGY, 2017, 234 (02) : 199 - 209
  • [42] Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study
    Suresh Durgam
    William M. Greenberg
    Dayong Li
    Kaifeng Lu
    Istvan Laszlovszky
    Gyorgy Nemeth
    Raffaele Migliore
    Stephen Volk
    Psychopharmacology, 2017, 234 : 199 - 209
  • [43] Open-label, long-term safety study of zonisamide administered to children with epilepsy
    Shinnar, S
    Pellock, JM
    Conry, JA
    NEUROLOGY, 2006, 66 (05) : A37 - A37
  • [44] Dose tapering to withdrawal stage and long-term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open-label extension study
    Mei, Heng
    Liu, Xiaofan
    Li, Yan
    Zhou, Hu
    Feng, Ying
    Gao, Guangxun
    Cheng, Peng
    Huang, Ruibin
    Yang, Linhua
    Hu, Jianda
    Hou, Ming
    Yao, Yazhou
    Liu, Li
    Wang, Yi
    Wu, Depei
    Zhang, Liansheng
    Zheng, Changcheng
    Shen, Xuliang
    Hu, Qi
    Liu, Jing
    Jin, Jie
    Luo, Jianmin
    Zeng, Yun
    Gao, Sujun
    Zhang, Xiaohui
    Zhou, Xin
    Shi, Qingzhi
    Xia, Ruixiang
    Xie, Xiaobao
    Jiang, Zhongxing
    Gao, Li
    Bai, Yuansong
    Xiong, Junye
    Li, Runzi
    Zou, Jianjun
    Niu, Ting
    Yang, Renchi
    Hu, Yu
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (03) : 716 - 728
  • [45] A PROSPECTIVE, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE EFFICACY, SAFETY AND ACCEPTABILITY OF PERICOITAL ORAL CONTRACEPTION WITH LEVONORGESTREL
    Lendvay, A.
    Taylor, D.
    Halpern, V
    Bahamondes, L.
    Fine, P.
    Guide, S.
    Raymond, E.
    CONTRACEPTION, 2012, 86 (03) : 313 - 313
  • [46] A Multicenter, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Saroglitazar in Patients With Primary Biliary Cholangitis
    Vuppalanchi, Raj
    Gonzalez-Huezo, Ma Sarai
    Payan-Olivas, Ramon
    Munoz-Espinosa, Linda E.
    Shaikh, Farheen
    Cruz-Lopez, Jose L. Pio
    Parmar, Deven
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (04) : E00327
  • [47] Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
    Ito, Shuichi
    Nishiyama, Yuya
    Sugiura, Kenkichi
    Enya, Kazuaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (04) : 350 - 358
  • [48] Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
    Shuichi Ito
    Yuya Nishiyama
    Kenkichi Sugiura
    Kazuaki Enya
    Clinical and Experimental Nephrology, 2022, 26 : 350 - 358
  • [49] EFFICACY AND SAFETY OF ADJUNCTIVE LURASIDONE IN TREATMENT RESISTANT UNIPOLAR DEPRESSION : AN OPEN-LABEL SINGLE-ARM PILOT STUDY
    Chiu, Nan-Ying
    Chang, Cheng-Ju
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i324 - i325
  • [50] Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
    Gevaert, Philippe
    Saenz, Rebecca
    Corren, Jonathan
    Han, Joseph K.
    Mullol, Joaquim
    Lee, Stella E.
    Ow, Randall A.
    Zhao, Rui
    Howard, Monet
    Wong, Kit
    Islam, Lutaf
    Ligueros-Saylan, Monica
    Omachi, Theodore A.
    Bachert, Claus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 957 - +
12345